Aksys Ltd (AKSY)

[HARVARD LAW]

Industry : Medical Instruments & Supplies
Employees : 87
Exchange : Other OTC Issues

Aksys, Ltd. (Aksys) was established to provide hemodialysis products and services for patients suffering from end-stage renal disease (ESRD), commonly known as chronic kidney failure. The Company has developed an automated personal hemodialysis system, known as the Aksys Personal Hemodialysis (PHD) System (the PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites (such as their own homes), and to thereby improve clinical outcomes, reduce total ESRD treatment costs and enhance the quality of life of patients. The Company’s target market is the ESRD treatment market. A healthy human kidney continuously removes waste products and excess water from the blood. ESRD is a slow, progressive loss of kidney function caused by inherited disorders, prolonged medical conditions, such as diabetes and hypertension, or the long-term use of certain medications. ESRD is irreversible and lethal if untreated.